TGINSIGHT SIMILAR POSTS
Source channel @githubtrending · Post #15064 · Aug 16
#csharp#2d#avaloniaui#csharp#dotnet_core#dotnetcore#editor#game_development#graphics#graphics_editor#linux_desktop#painting#pixel_art#pixi#procedural_drawing#procedural_generation#raster_graphics#sprites#tabs#vector_graphics PixiEditor is a free, easy-to-use 2D graphics editor that combines pixel art, painting, and vector tools all in one program. You can create game sprites, animations, logos, and edit images with a simple interface. It supports mixing vector and raster graphics on the same canvas and lets you export to many formats like PNG, SVG, GIF, and MP4. The powerful Node Graph system allows you to create complex, non-destructive effects and animations. It also has a timeline for frame-by-frame animation and autosaves your work to prevent loss. This makes it a versatile tool for artists and game developers. https://github.com/PixiEditor/PixiEditor
Search: #biotechnology
@venturevillagewall · Post #3500 · 12/19/2024, 01:59 PM
Xcell Biosciences Secures $1.4M Xcell Biosciences has raised $1.40 million for advancing its cell therapy manufacturing. The funding round took place on December 17, 2024. Learn more at Xcell Biosciences #XcellBiosciences#Funding#CellTherapy#SanFrancisco#Biotechnology#HealthTech
@venturevillagewall · Post #3574 · 12/20/2024, 09:33 AM
Tessera Therapeutics Secures $50M Tessera Therapeutics has raised $50 million in funding on December 18, 2024. The early-stage life sciences company is at the forefront of Gene Writing™, a cutting-edge biotechnology aimed at transforming medicine and scientific research. More details available on their official website: Tessera Therapeutics #TesseraTherapeutics#Funding#LifeSciences#Biotechnology#GeneWriting#Healthcare#MedicalResearch
@venturevillagewall · Post #3627 · 12/21/2024, 10:22 AM
First Oral Diabetes Therapy Funded TIXiMED has raised $2.65 million to develop TXNIP inhibiting medication, targeting Type 1 and Type 2 Diabetes with an innovative oral therapeutic. Learn more about their project here. #TIXiMED#Diabetes#Funding#Healthcare#TXNIP#Therapeutics#Type1Diabetes#Type2Diabetes#Biotechnology
@venturevillagewall · Post #3582 · 12/20/2024, 09:34 AM
$140M Funding for Ottimo Pharma Ottimo Pharma announces a funding round of $140 million set for December 19, 2024. The company focuses on developing bi-functional medicines aimed at improving the lives of individuals living with cancer. Learn more #Funding#OttimoPharma#Cancer#BiFunctionalMedicines#Healthcare#Pharmaceuticals#LifeSciences#Investments#MedicalResearch#Oncology#HealthTech#Biotechnology
@venturevillagewall · Post #3557 · 12/20/2024, 09:32 AM
Spine BioPharma Raises $13.51M Spine BioPharma has successfully closed a funding round totaling $13.51 million, announced on December 18, 2024. For more details, visit their official site: Spine BioPharma. #SpineBioPharma#Funding#BioPharma#Investment#Healthcare#LifeSciences#VentureCapital#Startup#ClinicalTrials#MedicinalResearch#Pharma#Innovations#Tech#Biotechnology#Market#Earnings#Growth#Investors#Equity
@venturevillagewall · Post #3629 · 12/21/2024, 10:22 AM
$4.07M Funding for PeptiSystems PeptiSystems secured $4.07M in funding on December 20, 2024. The company develops advanced instruments for solid-phase synthesis in peptide and oligonucleotide therapeutics, catering to both GMP and non-GMP manufacturing. Discover more: PeptiSystems #Funding#PeptiSystems#Therapeutics#Peptides#Oligonucleotides#GMP#Manufacturing#Synthesis#Biotechnology#Pharmaceuticals#MedicalDevices#FlowthroughColumnTechnology#ProcessDevelopment#LifeSciences